Correction to:  Allantopyrone A interferes with multiple components of the TNF receptor 1 complex and blocks RIP1 modifications in the TNF-α-induced signaling pathway; 4-O-Methylascochlorin inhibits the prolyl hydroxylation of hypoxia-inducible factor-1α, which is attenuated by ascorbate

https://doi.org/10.1038/ja.2017.74, published online 5 July 2017

https://doi.org/10.1038/s41429-019-0157-0, published online 22 February 2019

In the section “Western blotting” in “Materials and Methods”, sentence 3, “β-actin” has been replaced with “γ1 -actin”. All other mentions of “β-actin” have been replaced with “actin”. Figures 2, 3, 4, 5, 6 and 7 have also been replaced to change “β-actin” to “actin”.

In the section “Antibodies” in “Materials and methods”, sentence 1, “β-actin (2F3; FUJIFILM Wako Pure Chemical, Osaka, Japan)” has been replaced with “β-actin (AC-15; Sigma-Aldrich, St. Louis, MO, USA), γ1-actin (2F3; FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan)”. All other mentions of “β-actin”, except for those in the section “Quantative PCR” in “Materials and Methods”, sentence 3; Fig. 2c legend, sentence 3; Fig. 4b, c legend, sentence 3; and Fig. 6b legend, sentence 3 have been replaced with “actin”. Figures 1, 3, 5, 6 and Supplementary Information have also been replaced to change “β-actin” to “actin”.